Results 181 to 190 of about 22,304 (253)

Recent investigations on the impact of levonorgestrel and 17β-ethinylestradiol on melanoma. [PDF]

J Med Life
Borozan F, Semenescu AD, Tomescu L, Sas I.   +3 more
europepmc   +1 more source

Experiences of the use of the levonorgestrel intrauterine device for heavy menstrual bleeding: Device discontinuation rates and reasons for discontinuation among users at a regional hospital in the Western Cape - A seven-year review

Albe C. Swanepoel, Trudy Leong, Tonya M. Esterhuizen, G. Gebhardt   +3 more
openalex   +1 more source

Safety of repeated use of emergency contraceptive pills in the same menstrual cycle: a systematic review. [PDF]

BMJ Sex Reprod Health
Steyn PS, Fleurant E, Smith EM, Kiarie JN.   +3 more
europepmc   +1 more source

Oncological safety and fertility outcomes of controlled ovarian stimulation in patients with early-stage endometrial cancer. [PDF]

F S Rep
Kastora SL, Armata I, Chandrasekaran D, Graham R, MacDonald N, Yasmin E.   +5 more
europepmc   +1 more source

Impact of Levonorgestrel-Releasing Intrauterine Devices on Magnetic Resonance Imaging of the Breast. [PDF]

Breast Care (Basel)
Müller J, Körnig M, Farkas M, Reeve K, Pisarcik D, Kubik-Huch RA, Leo C.   +6 more
europepmc   +1 more source

Perioral dermatitis secondary to topical clascoterone 1. [PDF]

JAAD Case Rep
Noda M, Zureigat M.
europepmc   +1 more source

One-year continuation of the etonogestrel contraceptive implant initiated with oral emergency contraception. [PDF]

Contraception
Gawron LM, Sexsmith CD, Carter G, Kaiser JE, Woodcock A, Turok DK.   +5 more
europepmc   +1 more source

Emergency contraception in primary health care. [PDF]

S Afr Fam Pract (2004)
Govender I, Adeleke OA, Govender LL, Omole OB.   +3 more
europepmc   +1 more source